Stock reports › US › Technology

International Business Machines Corporation (IBM) stock analysis

IBM near its 200-day average after a volatile year, with steady cash flow and a modest earnings growth outlook

IBM closed at 248.22 on Nov 11, 2026, 25.34% below its 52-week high of 332.46 and roughly at its 200-day average of 247.25. The company posted TTM free cash flow of $14.34B and a forward P/E of 18.88, but revenue growth ranks in the 17th percentile of US Technology peers. Analysts rate it Buy on average with a mean target of 260.85, while leverage is high and the stock has fallen 16.20% year to date.

  • Price: 231.09
  • Market Cap (USD): $218.24B
  • P/E: 19.54×
  • Fwd P/E: 17.56×
  • Div Yield: 2.92%
  • 1Y Return: -24.40%
  • Next Earnings: Jan 27, 2027
  • Mean Target: 261.88
  • Rating: Buy

Bull case

  • Free cash flow was 14.34B over the trailing twelve months, with free cash flow growth of 17.77% year over year and a free cash flow yield of 6.12% (75th percentile of US Technology).
  • The latest quarter (Oct 21, 2026) beat consensus EPS by 3.51% (2.95 vs 2.85) and revenue by 1.68%, and several analysts raised targets on Oct 22, including Goldman Sachs to 300 from 270.
  • Forward P/E of 18.88 sits just below the sector median of 19.33 while the dividend yield of 2.72% is in the 96th percentile, backed by 29 years of dividend growth.

Bear case

  • Growth lags peers: revenue growth of 6.83% year over year is in the 17th percentile (sector median 18.95%), and next year's EPS growth of 6.84% is in the 11th percentile.
  • The balance sheet is leveraged, with total debt of 67.14B, net debt to EBITDA of 3.16, a current ratio of 0.85 and debt to equity in the 93rd percentile of the sector.
  • The stock is down 19.70% over one year, the death cross dated Mar 12, 2026 remains in place (50-day average 3.94% below the 200-day), and earnings reactions have been large, including -9.62% after Apr 22, 2026.

What to watch

  • Next earnings on Jan 27, 2027 (not yet confirmed), with consensus EPS of 4.63.
  • The 200-day average at 247.25 and 50-day average at 237.51 as nearby trend levels.
  • The 20-day high of 259.87 and low of 226.01, then the 52-week high of 332.46 and low of 199.19.
  • The next dividend payment of 1.69 per share on Dec 10, 2026 (ex-dividend date was Nov 10, 2026).

General

IBM is a mega-cap technology company with software, consulting, infrastructure and financing segments. Cash generation and a high dividend yield contrast with slower growth than peers, high leverage and a share price well below its 52-week high. Analysts lean positive, though the target upside is modest.

Business and performance

IBM operates in Software (including Red Hat), Consulting, Infrastructure and Financing. In fiscal 2025 Software was 44.41% of revenue and Consulting 31.21%. Trailing revenue is $69.87B with a net margin of 15.99%. Revenue growth was 6.83% year over year and 4.73% in the latest quarter.

Valuation in context

Forward P/E is 18.88 versus a sector median of 19.33 and an industry median of 11.69. Price to sales of 3.36 is in the 27th percentile. The PEG ratio of 2.76 reflects slower expected EPS growth of 6.84% next year, so the valuation looks middling relative to growth.

Analysts and market signals

The consensus label is Buy with a mean target of 260.85, 5.09% above the price, from 13 analysts. Evercore ISI reiterated Outperform on Nov 6, 2026. Recent news includes a quantum chip unveiling on Nov 11 and an AI agent platform announced with Microsoft on Nov 10. Short interest is low at 1.89% of float.

Long-term investor

IBM shows steady revenue growth, strong cash flow and a long dividend record, with returns on equity boosted by leverage. Growth and ROIC trail peers, and the balance sheet carries significant debt. Valuation is near the sector median.

Growth and margins

Revenue rose from 55.18B in fiscal 2020 to 67.54B in fiscal 2025, a 3-year CAGR of 3.72% and 5-year CAGR of 4.12%. Operating margin is 17.98% (51st percentile) and gross margin 57.96%. Free cash flow margin is 20.53%. Fiscal 2025 EPS of 11.17 compares with 6.43 in fiscal 2024.

Returns and balance sheet

ROE is 35.21% (76th percentile) but ROIC is 10.83%, below the sector median of 16.22%. Total debt is 67.14B against cash of 11.06B, interest coverage is 6.52 and the Piotroski score is 7. Goodwill of 74.92B is large relative to equity of 35.54B.

Capital return and sentiment

Dividends paid were 6.25B in fiscal 2025 with a payout ratio of 57.40%, but dividend growth over three years is only 0.60%. Fiscal 2025 buybacks were 0.00. One insider sale of 5.8M was recorded on Aug 26, 2026 and no buys. Institutional ownership is 66.00%, up 2.76% over three months. Estimates are edging up: EPS revisions of 0.83% over 30 days.

Swing trader

IBM is consolidating around its 20-day and 200-day averages with neutral momentum and weak trend strength. Levels are clearly defined between the 226.01 20-day low and the 259.87 20-day high. Earnings are 77 days away, outside a typical swing window.

Trend and momentum

Price of 248.22 is 0.04% above the 20-day average (248.13), 4.51% above the 50-day (237.51) and 0.39% above the 200-day (247.25). RSI is 54.82, ADX is 20.03 (weak trend), and MACD of 3.46 is below its signal of 4.66. The death cross from Mar 12, 2026 persists.

Recent action and levels

The stock fell from 258.28 on Oct 29 to 244.53 on Nov 10, then gained 1.51% on Nov 11 on 3.4M shares, 0.64 times relative volume. Resistance sits near 259.87 and 262.47 (upper Bollinger band); support near 233.78 and 226.01. ATR is 6.93, or 2.79% of price.

Flow and positioning

Analyst actions were mostly reiterations; Susquehanna set a 275 target on Nov 6, 2026. Short interest fell to 17.8M shares (1.89% of float) as of Oct 30, 2026, down 10.41%. The relative strength rating is 58, with 3-month relative strength of 6.56%.

Options

Implied volatility is moderate and low in its 52-week range, yet still above recent realized volatility, so premium looks somewhat rich. Liquidity is strong and flow is call-heavy. No earnings fall inside the 30-day expiry.

Volatility level and premium

30-day implied volatility is 32.26%, with an IV rank of 25 and IV percentile of 21 versus a 52-week range of 22.46% to 61.85%. It fell 12.8 points over 20 days. Against 30-day historical volatility, the spread is +6.8 points (ratio 1.27), a volatility risk premium of +5.2 points.

Term structure and expected moves

The term structure is in contango, with 90-day implied volatility of 35.67% (+3.4 points over 30-day). The 25-delta skew is +1.2 points. The 30-day expected move is 9.25% (22.96), and the 7-day move is 4.47% (11.09). The Dec 11, 2026 expiry has no earnings before it.

Earnings history, yield and liquidity

Past actual earnings moves averaged 5.22% over four quarters and 6.10% over eight, with a maximum of 14.45% and average IV crush of 21.91%. For the 30-day expiry, the 240.00 put gives a cash-secured put yield of 27.67% annualized and the 265.00 call a covered-call yield of 17.92%. Liquidity score is 95; put/call volume ratio is 0.34.

Analysis written November 12, 2026 from Qanvo data as of November 11, 2026. AI-generated, for information only; not investment advice.